Because the peptide is absorbed gradually through the digestive system, it allows for sustained release over a longer period
The agency proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, the set of active ingredients that large-scale outsourcing facilities may compound from in bulk
The most common side effects include nausea (occurring in up to 30% of users at higher doses), diarrhea, constipation, decreased appetite, vomiting, and abdominal pain
Prescriptions are only provided if medically appropriate after consultation
Presented for research literature review only Kalogjera L et al
Data are lacking from long-term studies to assess whether oral treatment is effective when doses are administered less frequently than daily